654 related articles for article (PubMed ID: 26939770)
1. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
[TBL] [Abstract][Full Text] [Related]
4. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
[TBL] [Abstract][Full Text] [Related]
5. A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.
Huang Z; Nair M
Sci Rep; 2017 Jul; 7(1):5955. PubMed ID: 28729655
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.
Li C; Guan X; Du T; Jin W; Wu B; Liu Y; Wang P; Hu B; Griffin GE; Shattock RJ; Hu Q
J Gen Virol; 2015 Aug; 96(8):2381-2393. PubMed ID: 25854553
[TBL] [Abstract][Full Text] [Related]
9. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA.
Zhu W; Lei R; Le Duff Y; Li J; Guo F; Wainberg MA; Liang C
Retrovirology; 2015 Feb; 12():22. PubMed ID: 25808449
[TBL] [Abstract][Full Text] [Related]
10. Elimination of infectious HIV DNA by CRISPR-Cas9.
Das AT; Binda CS; Berkhout B
Curr Opin Virol; 2019 Oct; 38():81-88. PubMed ID: 31450074
[TBL] [Abstract][Full Text] [Related]
11. Genome scale screening identification of SaCas9/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection.
Wang Q; Liu S; Liu Z; Ke Z; Li C; Yu X; Chen S; Guo D
Virus Res; 2018 May; 250():21-30. PubMed ID: 29625148
[TBL] [Abstract][Full Text] [Related]
12. A CRISPR/Cas9 library to map the HIV-1 provirus genetic fitness.
Yoder KE
Acta Virol; 2019; 63(2):129-138. PubMed ID: 31230441
[TBL] [Abstract][Full Text] [Related]
13. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.
Hou P; Chen S; Wang S; Yu X; Chen Y; Jiang M; Zhuang K; Ho W; Hou W; Huang J; Guo D
Sci Rep; 2015 Oct; 5():15577. PubMed ID: 26481100
[TBL] [Abstract][Full Text] [Related]
14. Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line.
Liu Y; Jeeninga RE; Klaver B; Berkhout B; Das AT
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960730
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
Ophinni Y; Inoue M; Kotaki T; Kameoka M
Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9: a double-edged sword when used to combat HIV infection.
Liang C; Wainberg MA; Das AT; Berkhout B
Retrovirology; 2016 May; 13(1):37. PubMed ID: 27230886
[No Abstract] [Full Text] [Related]
17. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
Han Y; Li QW
Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
[TBL] [Abstract][Full Text] [Related]
18. Negative Feedback Regulation of HIV-1 by Gene Editing Strategy.
Kaminski R; Chen Y; Salkind J; Bella R; Young WB; Ferrante P; Karn J; Malcolm T; Hu W; Khalili K
Sci Rep; 2016 Aug; 6():31527. PubMed ID: 27528385
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
Wang G; Zhao N; Berkhout B; Das AT
Mol Ther; 2016 Mar; 24(3):522-6. PubMed ID: 26796669
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9: a tool to eradicate HIV-1.
Bhowmik R; Chaubey B
AIDS Res Ther; 2022 Dec; 19(1):58. PubMed ID: 36457057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
